ArticleScientific reports2025
A novel data-driven model to define physical activity metrics and predict mortality in patients with chronic obstructive pulmonary disease.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Physical activity (PA) is a well-established prognostic marker in Chronic Obstructive Pulmonary Disease (COPD). Traditional PA metrics, such as step count, often overlook movement intensity, while energy expenditure (EE) relies on indirect calorimetry assumptions. To address these limitations, we propose a data-driven PA metric that integrates movement frequency and amplitude derived from raw accelerometer data. This retrospective analysis, based on a Dutch COPD database, also evaluates the predictive value of the new score for mortality in COPD patients compared to step count and energy expenditure. Movement data and step counts were collected using McRoberts triaxial accelerometers. Fourier analysis was applied to extract movement frequency and amplitude, which were then used to compute the physical activity (PA) score. Kolmogorov-Smirnov test was conducted to assess whether the distributions of step count and PA score differed, followed by Kruskal-Wallis test to assess day-to-day movement variability. Logistic regression was used to evaluate and compare the predictive performance of the novel PA score against step count and EE. A total of 404 COPD patients (51.5% female; median [IQR] age: 57 [46-66] years) were included. The proposed PA score and step count exhibited similar daily patterns but differed significantly in distribution. Mortality data were available for 165 participants. The PA score achieved 2.8% higher accuracy and 5.6% higher balanced accuracy than step count in mortality prediction, while EE demonstrated the lowest predictive performance. The proposed PA score demonstrates stronger predictive power for mortality in COPD patients, highlighting the importance of integrating movement characteristics beyond simple step count, and offering a more refined metric for PA evaluation in both clinical and research settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.